This list is an analysis based on recent market events. It's not an investment recommendation.
About
Established in Tainan City, Taiwan, in 2001, Sunmax Biotechnology Co., Ltd. functions as a biomedical enterprise. The company specializes in the development, manufacturing, and commercialization of collagen-based medical devices across Taiwan and mainland China. Its diverse product line encompasses Porcogen, a sterile, purified collagen solution valuable for medical device applications, tissue engineering, and research. Sunmax also supplies various dermal fillers, including the Sunmax collagen implant series (I-Plus, I) and FACIALGAIN collagen implants (with and without lidocaine), engineered for correcting facial aesthetic concerns such as wrinkles. For dental procedures, they provide specialized collagen-based solutions like Sunmax collagen dental bone grafts, membranes, and granules, used for augmenting or reconstructing the alveolar ridge, extraction sockets, and in periodontics. Additionally, the Sunmax collagen bone graft matrix serves as a bone void filler that naturally resorbs and facilitates new bone formation during recovery. The company's offerings extend to skincare products, such as Sunmax 12 jiao didi spray, Sunmax 11 collagen moisturizing cream, and a general collagen skincare line, all designed for post-dermal filler treatment aftercare.
The current price of 4728.TWO is TWD389.00 TWD — it has decreased by -1.52% in the past 24 hours. Watch Sunmax Biotechnology. stock price performance more closely on the chart.
What is Sunmax Biotechnology. stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Taiwan OTC Exchange exchange Sunmax Biotechnology. stocks are traded under the ticker 4728.TWO.
Is Sunmax Biotechnology. stock price growing?▼
4728.TWO stock has fallen by -3.35% compared to the previous week, the month change is a -1.39% fall, over the last year Sunmax Biotechnology. has showed a -1.02% decrease.
What is Sunmax Biotechnology. market cap?▼
Today Sunmax Biotechnology. has the market capitalization of 21.19B
What is Sunmax Biotechnology. revenue for the last year?▼
Sunmax Biotechnology. revenue for the last year amounts to 2.03B TWD.
What is Sunmax Biotechnology. net income for the last year?▼
4728.TWO net income for the last year is 725.75M TWD.
Does Sunmax Biotechnology. pay dividends?▼
Yes, 4728.TWO dividends are paid annual. The last dividend per share was 12.1 . As of today, Dividend Yield (FWD)% is 3.11%.
How many employees does Sunmax Biotechnology. have?▼
As of November 4, 2026, the company has 30 employees.
In which sector is Sunmax Biotechnology. located?▼
Sunmax Biotechnology. operates in the Health & Wellness sector.
When did Sunmax Biotechnology. complete a stock split?▼
Sunmax Biotechnology. has not had any recent stock splits.
Where is Sunmax Biotechnology. headquartered?▼
Sunmax Biotechnology. is headquartered in Tainan City, Taiwan.